Lorazepam is one of the most widely prescribed benzodiazepines in the United States and, at the same time, one of the most closely monitored. Sold most commonly under the brand name Ativan, it is used to treat anxiety disorders and for short-term relief of anxiety symptoms . For many patients it provides meaningful relief, particularly in acute or short-term situations. It is also a medication with a well-documented set of properties — dependence, withdrawal, sedation, respiratory effects, and interaction risks — that make how it is prescribed and taken genuinely important.
This guide covers lorazepam in full: what it is, its generic name and class, its approved uses, how it works, its effects, its legal classification, and what appropriate medical access and monitoring look like.
Lorazepam is the generic name of a medication in the benzodiazepine class. It is most widely known by the brand name Ativan, though many generic manufacturers produce it .
Immediate-release tablets are available in 0.5 mg, 1 mg, and 2 mg strengths . The usual dosage range is 2 to 6 mg per day given in divided doses, though the daily dosage may vary from 1 to 10 mg per day depending on the patient .
Oral concentrate is available for patients who have difficulty swallowing tablets. Injection is used in healthcare settings for specific clinical purposes.
Lorazepam is a benzodiazepine with anxiolytic, sedative, and muscle-relaxant properties. It is a federal controlled substance (C-IV) because it can be abused or lead to dependence .
Lorazepam has specific, well-defined approved indications.
Lorazepam tablets are indicated for the treatment of anxiety disorders .
Lorazepam is also indicated for the short-term relief of the symptoms of anxiety or anxiety that can happen with symptoms of depression .
The FDA labeling is direct about treatment duration: it is not known if lorazepam tablets are safe and effective for use for longer than 4 months . In practice, lorazepam is generally understood as a short-term or intermittent treatment rather than a permanent daily therapy for most patients.
Primary depressive disorder or psychosis — lorazepam is not recommended for use in patients with a primary depressive disorder or psychosis
Everyday stress unrelated to a diagnosed anxiety disorder
Long-term daily use without periodic reassessment
Use in children under 12 — safety and effectiveness have not been established
Lorazepam, like all benzodiazepines, works by enhancing the activity of gamma-aminobutyric acid (GABA) at GABA-A receptors in the brain. GABA is the primary inhibitory neurotransmitter in the central nervous system — it reduces neuronal excitability throughout the brain.
Benzodiazepines bind to a specific site on the GABA-A receptor complex and increase the frequency of chloride channel opening, which hyperpolarizes neurons and makes them less likely to fire. The net effect is reduced anxiety, relaxation of muscle tension, and sedation.
Lorazepam has a relatively long duration compared with some shorter-acting benzodiazepines, which is relevant to its dosing schedule and its withdrawal profile. Its effects generally last through a substantial portion of the day.
This is the clinical core of what lorazepam is, and it is not optional information.
Lorazepam carries a boxed warning for abuse and dependence. Taking lorazepam can cause physical and psychological dependence . Physical dependence is not the same as drug addiction; physical dependence describes the body's adaptation to the medication, such that stopping it produces withdrawal effects.
Tolerance to lorazepam may develop from continued therapy. Tolerance is a physiological state characterized by a reduced response to a drug after repeated administration — a higher dose is required to produce the same effect that was once obtained at a lower dose .
Stopping lorazepam abruptly after prolonged use can produce withdrawal symptoms. The labeling warns: "You may have withdrawal symptoms if you stop taking lorazepam tablets suddenly. Withdrawal symptoms can be serious and include seizures." Mild withdrawal symptoms include a depressed mood and trouble sleeping .
Abrupt discontinuation or rapid dosage reduction may precipitate acute withdrawal reactions, including seizures, which can be life-threatening . To reduce the risk of withdrawal reactions, the labeling directs using a gradual taper to discontinue lorazepam or reduce the dosage .
A protracted withdrawal syndrome associated with benzodiazepines is characterized by anxiety, cognitive impairment, depression, insomnia, formication, motor symptoms (weakness, tremor, muscle twitches), paresthesia, and tinnitus that persists beyond 4 to 6 weeks after initial withdrawal. Protracted withdrawal symptoms may last weeks to more than 12 months .
Patients at an increased risk of withdrawal adverse reactions include those who take higher dosages and those who have had longer durations of use .
Lorazepam is a CNS depressant. It produces sedation, drowsiness, and reduced alertness. The labeling warns: "Do not drive, operate heavy machinery, or do other dangerous activities until you know how lorazepam tablets affect you" .
Benzodiazepines, including lorazepam, can cause respiratory depression. The labeling carries a boxed warning regarding the combined use of benzodiazepines with opioids, alcohol, or other central nervous system depressants (including street drugs), which can cause severe drowsiness, breathing problems (respiratory depression), coma and death .
Elderly or debilitated patients may be more susceptible to the sedative effects of lorazepam. For these patients, an initial dosage of 1 to 2 mg/day in divided doses is recommended, adjusted as needed and tolerated .
The most commonly reported adverse reactions with lorazepam are :
Sedation
Dizziness
Weakness
Unsteadiness
These are not all the possible side effects. Any persistent or distressing effect should be reported to the prescriber.
Lorazepam's prescribing information contains multiple boxed warnings. These are the most serious warning category the FDA uses, and they reflect documented clinical events.
The most prominent boxed warning addresses combined use with opioids. This combination can result in profound sedation, respiratory depression, coma, and death. The labeling directs that concomitant prescribing be reserved for patients for whom alternative treatment options are inadequate, and that doses and durations be limited to the minimum required .
There is a risk of abuse, misuse, and addiction with benzodiazepines including lorazepam, which can lead to overdose and serious side effects including coma and death .
As described above, lorazepam carries a boxed warning for dependence and withdrawal. The risk increases with higher doses and longer duration, and withdrawal symptoms can occur after abrupt discontinuation or rapid dose reduction .
Pre-existing depression may emerge or worsen during use of benzodiazepines including lorazepam .
Lorazepam may harm an unborn baby. Benzodiazepines cross the placenta and may produce respiratory depression, hypotonia, and sedation in neonates. Neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal .
Lorazepam passes into breast milk and may harm the baby. Breastfeeding is not recommended while taking lorazepam. Infants exposed through breast milk should be monitored for sedation, poor feeding, and poor weight gain .
Hepatic impairment — Lorazepam should be used with caution in patients with liver problems .
Renal impairment — Usual precautions for treating patients with impaired renal function should be observed.
Seizures — Patients with a history of seizures should inform their prescriber .
Lorazepam interacts with a significant number of medications and substances. Anyone taking it should disclose all medications, supplements, and recreational substances to their prescriber and pharmacist.
Notable interactions include:
Opioids — Profound sedation and respiratory depression; this is the most serious interaction and the subject of a boxed warning .
Alcohol — Specifically warned against; compounds sedation and psychomotor impairment .
Other CNS depressants — Sleeping medications, muscle relaxants, and antihistamines can compound sedation and respiratory effects.
Valproate — Concurrent administration with valproate results in increased lorazepam levels and reduced clearance .
This is not an exhaustive list. A pharmacist consultation is advisable before starting any new medication while taking lorazepam.
Given all of the above, the appropriate path to lorazepam treatment is straightforward in principle and important to understand clearly.
Anxiety disorders are diagnosed through clinical evaluation — a structured interview, assessment of symptom duration and severity, medical history, and screening for other conditions. There is no single test that diagnoses an anxiety disorder; a real evaluation takes time and clinical judgment.
Lorazepam is a Schedule IV controlled substance under the federal Controlled Substances Act . This means it requires a prescription from a licensed prescriber with a valid DEA registration. Schedule IV status permits refills in some circumstances, subject to state law and prescriber discretion, but still requires an established prescriber-patient relationship.
Prescriptions are dispensed by a licensed pharmacy. Pharmacists verify prescriptions and may check prescription drug monitoring programs.
Prescribers periodically reassess whether continued treatment is appropriate. Monitoring typically includes:
Dose appropriateness and duration
Sedation and functional effects
Signs of dependence or misuse
Mood changes, including depression or suicidal ideation
Interactions with other medications
Periodic attempts at tapering when appropriate
When lorazepam is discontinued, the prescribing information directs a gradual taper to reduce the risk of withdrawal reactions . Tapering schedules should be set with a clinician, particularly after long-term use or at higher doses. Abrupt discontinuation is associated with withdrawal effects, including the more serious reactions described earlier.
Lorazepam is most commonly sold under the brand name Ativan .
Lorazepam is FDA-approved for anxiety disorders and for the short-term relief of the symptoms of anxiety or anxiety that can happen with symptoms of depression .
No. The labeling warns that stopping suddenly can cause withdrawal symptoms, which can be serious and include seizures. A gradual taper is directed .
Combining lorazepam with opioids, alcohol, or other CNS depressants can cause severe drowsiness, breathing problems, coma, and death. This is the subject of a boxed warning .
Sedation, dizziness, weakness, and unsteadiness are among the most commonly reported effects .
Lorazepam may harm an unborn baby. Use should be discussed carefully with a healthcare provider. Breastfeeding is not recommended while taking lorazepam .
Seek medical attention for excessive sedation, slowed or difficult breathing, severe confusion, or thoughts of self-harm.
Lorazepam is an effective medication for anxiety disorders and short-term relief of anxiety symptoms when prescribed and monitored by a clinician. It is also a Schedule IV benzodiazepine with boxed warnings for dependence and withdrawal, and for combined use with opioids. Both of these things are true at once, and a complete understanding of the medication requires holding both.
The clinical framework around lorazepam — short-term use where possible, gradual tapering, careful attention to respiratory and psychiatric factors, and monitoring for dependence — exists because these effects are documented and clinically significant. Appropriate access runs through a licensed healthcare provider, a valid prescription, and a licensed pharmacy. For anyone exploring treatment for anxiety, the most important step is a conversation with a qualified clinician who can evaluate your specific situation and guide you toward the right option.
Comments